Αρχική World News How My Navy Career Helped Shape My Positive Attitude During My Hereditary...

How My Navy Career Helped Shape My Positive Attitude During My Hereditary Cancer Diagnosis

Dan “Dry Dock” Shockley is a retired United States Navy veteran and an 8-year hereditary attenuated familial adenomatous polyposis (AFAP) survivor with a permanent ileostomy. He is an active patient advocate across multiple organizations and strives to bring awareness to hereditary colon cancer. After receiving his AFAP diagnosis, he enrolled in the Johns Hopkins Hospital and Creighton University hereditary colon cancer registries. Through the years, he has requested and received Colon Cancer Month, Rare Disease Day, and Ostomy Awareness Day proclamations from the governors of Hawaii, Idaho, and Texas, as well as from the mayor of each town he resided in each of these states. His current advocacy efforts are to establish legislative jurisdiction to designate the 4th week of March as Hereditary Colon Cancer Awareness Week.

It was during my first and only colonoscopy at age 51 that 100 polyps were discovered embedded throughout my colon, rectum, and anus. I was immediately referred to a certified genetic counselor for further evaluation and genetic testing. The test results confirmed the diagnosis of attenuated familial adenomatous polyposis (AFAP), a genetic condition where a person develops colon polyps that could lead to colorectal cancer.

I knew nothing of this disease before meeting with my genetic counselor and colorectal surgeon. They began educating me on the condition in order to provide effective counseling regarding my options for diagnosis and treatment. They also educated me on my genetic situation so that I could choose how to best inform my family. By providing me with great care, they were essentially going to treat an entire family.

During my meeting with the genetic counselor, we discussed my family history of cancer. There was none that I or my siblings knew of. We also discussed the genetic mutation that I was thought to possibly have, which was familial adenomatous polyposis (FAP). But a gene sequencing DNA test would be able to determine the exact diagnosis. The results arrived 6 weeks later, confirming the rare diagnosis of AFAP, which is a subtype of FAP.

After my diagnosis, my health care team and I discussed the type of surgery I would need and what life would be like with an ostomy. I was eager to learn about the mutation, the type of surgery, and life as an ostomate. All of this information was a lot to digest. However, my military experience equipped me to adapt, improvise, and overcome. Throughout this process, my certified genetic counselor and colorectal surgeon encouraged me to read about my condition. I divided my research efforts into 3 phases: first, I would learn about AFAP. Then, I would learn about total proctocolectomy with ileostomy, which was the type of surgery I would receive. During this procedure, my colon, rectum, and anus would be removed (proctocolectomy), and then a piece of my small intestine would be pulled through an opening in my abdomen to pass waste out of my body (ileostomy). Then, I would learn about life with a permanent ostomy. To better prepare myself for life with AFAP, I created a binder to hold all my medical reports for future reference.

It’s important to note that I didn’t have any symptoms or family history when I was diagnosed with AFAP. The mutation manifested in my small intestine, stomach, and left eye, so I would also need routine ophthalmology examinations and endoscopic procedures of my stomach and small intestine. I embraced the diagnosis from the onset. That said, my mindset was, and still remains, not to dwell on things I’m unable to control, such as medical conditions. What I can control is my attitude. After 5 decades on God’s green earth, my positive attitude has brought me this far. So why change? Furthermore, worrying is not the cause of my condition. Therefore, worrying will not make it go away. Reading about such a diagnosis and asking my medical team members questions had a positive impact on my outlook.

During my 22-year Navy career, I learned that mental and physical strength are important attributes to possess, especially in the face of personal or professional adversity. I feel maintaining a positive attitude while committed to the mission is instrumental in achieving success. This was evident during my numerous deployments to the Persian Gulf. When faced with challenges, both physically and professionally, I maintain a positive attitude and use the many resources that allow me to better understand the situation. Challenges, such as a diagnosis of AFAP, are opportunities for me to overcome adversity.

For those experiencing a similar diagnosis, I suggest establishing and maintaining an open dialogue with family members as well as your medical team members, including your certified genetic counselor. I prepared a binder and retained as many documents about my case as I could. Reviewing medical researchers’ peer-reviewed publications has also been an invaluable source of information directly related to my diagnosis.

There were 2 acronyms I created shortly after my diagnosis and then ostomy surgery: Full Assurance Influenced Through Hope (FAITH) and Attitude Determines the Ability for a Positive Transformation (ADAPT). FAITH is believing in what we’re unable to see. For example, we can see the tree branches swaying in the breeze. However, we’re unable to see the breeze; we just see the effect of it. ADAPT is about learning to adjust. It’s been said we’re unable to change the direction of the wind. But what we can do is adjust our sails. After 22 years in the Navy assigned to 7 different ships, I’m good at adjusting. My positive attitude has had a direct impact on my strong faith and my ability to adapt to life as an ostomate with a rare disease. Hopefully, your positive attitude can do the same for you.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

Discovering the BRCA2 gene – 25 years on

A breast cancer cell. Credit: LRI EM Unit. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. “You...

Newly Developed RSClin Provides Prognostic Information in HR-positive, HER2-negative Early Breast Cancer

The online RSClin tool incorporating clinical-pathological data and the results of a 21-gene recurrence score (RS) was able to estimate the risk of distant...

Embracing Bravery When You Have a Genetic Cancer Disease

Emily Pinto Billcheck is a licensed social worker with experience in the mental health field. She is a von Hippel-Lindau (VHL) patient who inherited VHL from her...

Chemotherapy Administered for the First Diagnosed Testicular Cancer Reduces the Risk of Metachronous Contralateral Testicular Cancer Occurrence

Patients aged less than 30 years upon diagnosis of testicular cancer and those treated with surgery only are at higher risk of developing a...

New Research Looks for More Effective Breast Cancer Treatments for Black Women

Breast cancer affects people across all different backgrounds, but Black women in particular are more apt to get aggressive forms of the disease. They’re...

Palbociclib Plus Endocrine Therapy Does Not Improve PFS over Capecitabine in HR-positive, HER2-negative Aromatase Inhibitor Resistant Metastatic Breast Cancer

Although patients with hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative, aromatase inhibitor resistant metastatic breast cancer maintained quality of life...